Feb 20 (Reuters) - Integral Diagnostics Ltd (IDX) :
- FY24 REPLACEMENT AND GROWTH CAPEX EXPECTED BETWEEN A$30.0M TO A$40.0M.
- DECLARED DIVIDENDS PER SHARE OF 2.5 AU CENTS
- IMPROVEMENT INITIATIVES TO LEAD TO IMPROVEMENT IN 2H FY24 TRADING PERFORMANCE AND OPERATING EBITDA MARGIN VERSUS H1 FY24
- FOR JANUARY 2024 AND UP TO AND INCLUDING 15 FEB 2024, ACHIEVED SOLID REVENUE GROWTH 11.6%
News: IDX Integral Diagnostics Sees FY24 Replacement And Growth Capex Between A$30.0M To A$40.0M.
Add IDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
0.010(0.41%) |
Mkt cap ! $577.8M | |||
| Open | High | Low | Value | Volume |
| $2.46 | $2.49 | $2.45 | $912.3K | 369.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1990 | $2.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.49 | 10397 | 4 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.48 |
Change
0.010 ( 0.89 %) |
||||
| Open | High | Low | Volume | ||
| $2.47 | $2.49 | $2.46 | 166446 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| IDX (ASX) Chart |